Ocata Therapeutics Inc fka OCAT

[lasers]

To achieve NASDAQ listing $ACTCD, IMO, may perhaps sell sufficient am't of their New Preferred authorized 50 mil Shares to either a Pharma or Financial Partner to raise ~ + $60 to 80 mil to thereby qualify quickly for NASDAQ Global Select Market under certain conditions which requires $55 mil "Shareholder Equity Value" with a SEC filing as determined by the NASDAQ Listing Review Committee.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=105731286

Just saying there are a few options available to $ACTCD and Ted Myles + DR. Paul Wotton no doubt have a NASDAQ Listing + Partner strategy.

$ACTCD shareholders will have to wait for an $ACTCD PR clarification which should be IMO coming over the next 1 to 3 weeks.